Johnson & Johnson (JNJ) Dividend Stock Analysis


Johnson & Johnson (JNJ) is a leader in the pharmaceutical, medical device and consumer products industries. A household name company, JNJ runs a globally diversified business with mature business segments. A dividend payer and grower for 52 years, the company has made a lot of investors very rich and happy over the decades. As the global population ages, the demand for healthcare rises significantly and companies such as JNJ stand to benefit handsomely. This article evaluates the financials and presents a complete dividend stock analysis of Johnson & Johnson.

Continue reading here >

9 thoughts on “Johnson & Johnson (JNJ) Dividend Stock Analysis

  1. JNJ is a must have in every investor’s portfolio. I view it as slightly overvalued at this moment, I own small shares and reluctant to add position at the moment, I will definitely add shares on a price dip. Another great analysis, thank you for sharing.

    • I am in the same boat as you. I own a small position, but JNJ is a fantastic company that I would like to buy more. I will wait for a better price to add shares.

      Thanks for the feedback. Best wishes

  2. The health care sector had a really great year in 2014 and JNJ is one of the top players in it. I purchased some shares of JNJ and to date it has returned 11%. Been waiting for it to go on discount ever since to get more into the action. However, I question the performance for 2015, definitely up for grabs. : )

    Very nice analysis on JNJ, R2R!

    • Jeff,
      Yup – healthcare had a great year indeed. I believe it was the second best sector after Utilities in 2014. I first picked up my shares in JNJ in 2013, and have been waiting for a good price to add to my position. For now, that remains elusive…but I suppose that is to be expected of great companies such as JNJ. They always trade at a bit of a premium. For now, I remain on the sidelines.

      Glad you liked it. Happy investing.

  3. Dave says:

    Would you ever consider sharing some of your spreadsheets or ratio calculations? I keep running across conflicting numbers for even the simplest of things such as the 10y DGR for JNJ. Morningstar shows 9.7%, I saw passive income pursuit’s recent analysis on seeking alpha where he states an 8.75% 10y dgr, I’ve also seen other slight variations. I’ve tried computing myself comparing with Morningstar but I can’t quite flush out exactly what they’re using. Seems they take a true TTM and don’t project the current quarterly div of .75 out to the full year (so 2.80 TTM), but I’m still not tying out exactly to their 9.7% 10y dgr. I’d like to be able to run my own numbers given the morningstar raw data, they just have absolutely no documentation on how exactly they’re computing their figures.

Leave a Reply

Your email address will not be published. Required fields are marked *